Impact of endogenous and exogenous insulin on basal energy expenditure in patients with type 2 diabetes under standard treatment

American Journal of Clinical Nutrition

Volumn 94, Issue 6, 2011, Pages 1513-1518

  Ikeda, Kaori ^a   Fujimoto, Shimpei ^a   Goto, Masashi ^a   Yamada, Chizumi ^a   Hamasaki, Akihiro ^a   Shide, Kenichiro ^a   Kawamura, Takashi ^a   Inagaki, Nobuya ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; BASAL ENERGY EXPENDITURE; BODY COMPOSITION; CALORIMETRY; DIET THERAPY; ENERGY EXPENDITURE; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN RELEASE; INSULIN TREATMENT; JAPANESE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PULSE RATE;

ADIPOSE TISSUE; AGED; BASAL METABOLISM; BODY COMPOSITION; BODY FLUID COMPARTMENTS; CALORIMETRY, INDIRECT; DIABETES MELLITUS, TYPE 2; FEMALE; HEART RATE; HUMANS; INSULIN; MALE; MIDDLE AGED;

EID: 82355165161     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.017889     Document Type: Article

References (32)

1. American Diabetes Association, Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayer-Davis E, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008;31(suppl 1):S61-78.
2. Cunningham JJ. Body composition as a determinant of energy expenditure: a synthetic review and a proposed general prediction equation. Am J Clin Nutr 1991;54:963-9. (Pubitemid 21917660)
3. Javed F, He Q, Davidson LE, Thornton JC, Albu J, Boxt L, Krasnow N, Elia M, Kang P, Heshka S, Gallagher D. Brain and high metabolic rate organ mass: contributions to resting energy expenditure beyond fat-free mass. Am J Clin Nutr 2010;91:907-12.
4. Bitz C, Toubro S, Larsen TM, Harder H, Rennie KL, Jebb SA, Astrup A. Increased 24-h energy expenditure in type 2 diabetes. Diabetes Care 2004;27:2416-21. (Pubitemid 39281395)
5. Martin K, Wallace P, Rust PF, Garvey WT. Estimation of resting energy expenditure considering effects of race and diabetes status. Diabetes Care 2004;27:1405-11. (Pubitemid 38679991)
6. Ryan M, Sallé A, Guilloteau G, Genaitay M, Livingstone MB, Ritz P. Resting energy expenditure is not increased in mildly hyperglycaemic obese diabetic patients. Br J Nutr 2006;96:945-8. (Pubitemid 46454574)
7. Nair KS, Halliday D, Garrow JS. Increased energy expenditure in poorly controlled Type 1 (insulin-dependent) diabetic patients. Diabetologia 1984;27:13-6. (Pubitemid 14096661)
8. Gougeon R, Pencharz PB, Sigal RJ. Effect of glycemic control on the kinetics of whole-body protein metabolism in obese subjects with non-insulin-dependent diabetes mellitus during iso-and hypoenergetic feeding. Am J Clin Nutr 1997;65:861-70. (Pubitemid 27111097)
9. Bursztein S, Elwyn DH, Askanazi J, Kinney JM. Energy metabolism, indirect calorimetry, and nutrition. Baltimore, MD: Lippincott Williams & Wilkins, 1989.
10. Compher C, Frankenfield D, Keim N, Roth-Yousey L; Evidence Analysis Working Group. Best practice methods to apply to measurement of resting metabolic rate in adults: a systematic review. J Am Diet Assoc 2006;106:881-903. (Pubitemid 44250970)
11. Frary CD, Johnson RK. Energy. In: Mahan LK, Escott-Stump S. Krause's food & nutrition therapy. 12th ed. St. Louis, MO: Saunders/Elsevier, 2007:22-38.
12. Japan Diabetes Society. Treatment guide for diabetes. Tokyo, Japan: Bunkodo, 2007.
13. Henry CJ. Basal metabolic rate studies in humans: measurement and development of new equations. Public Health Nutr 2005;8:1133-52. (Pubitemid 43266303)
14. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949;109:1-9.
15. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011;34(suppl 1):S11-61.
16. The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 2010;1:212-28.
17. Faber OK, Binder C. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus. Diabetes 1977;26:605-10. (Pubitemid 8149645)
18. Weyer C, Bogardus C, Pratley RE. Metabolic factors contributing to increased resting metabolic rate and decreased insulin-induced thermogenesis during the development of type 2 diabetes. Diabetes 1999;48:1607-14. (Pubitemid 29356870)
19. Boden G, Chen X, Stein TP. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2001;280:E23-30.
20. Nelson DL, Cox MM. Lehninger principles of biochemistry. 5th ed. New York, NY: WH Freeman and Company, 2008.
21. Consoli A, Nurjhan N, Capani F, Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 1989;38:550-7. (Pubitemid 19125601)
22. Nuttall FQ, Ngo A, Gannon MC. Regulation of hepatic glucose production and the role of gluconeogenesis in humans: is the rate of gluconeogenesis constant? Diabetes Metab Res Rev 2008;24:438-58.
23. Stump CS, Nair KS. Alterations in protein metabolism in diabetes mellitus. 14th ed. In: Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ, eds. Joslin's diabetes mellitus. Boston, MA: Joslin diabetes center, 2005:275-90
24. Gougeon R, Morais JA, Chevalier S, Pereira S, Lamarche M, Marliss EB. Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes. Diabetes Care 2008;31:128-33.
25. Dunning BE, Gerich JE. The role of α-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. Endocr Rev 2007;28:253-8.
26. Charlton MR, Nair KS. Role of hyperglucagonemia in catabolism associated with type 1 diabetes. Diabetes 1998;47:1748-56.
27. Nonogaki K. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 2000;43:533-49. (Pubitemid 30322070)
28. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991;87:2246-52.
29. Fukushima M, Suzuki H, Seino Y. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res Clin Pract 2004;66:S37-43. (Pubitemid 39572582)
30. Dela F, von Linstow ME, Mikines KJ, Galbo H. Physical training may enhance β-cell function in type 2 diabetes. Am J Physiol Endocrinol Metab 2004;287:E1024.
31. Funakoshi S, Fujimoto S, Hamasaki A, Fujiwara H, Fujita Y, Ikeda K, Hamamoto Y, Hosokawa M, Seino Y, Inagaki N. Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure. Diabetes Res Clin Pract 2008;82:353-8.
32. Gougeon R, Lamarche M, Yale JF, Venuta T. The prediction of resting energy expenditure in type 2 diabetes mellitus is improved by factoring for glycemia. Int J Obes Relat Metab Disord 2002;26:1547-52. (Pubitemid 36099002)